* EMA - REITERATES ITS PREVIOUS ADVICE THAT PATIENTS SHOULD CONTINUE TO USE ACE INHIBITORS OR ARBS AS ADVISED BY THEIR DOCTORS * EMA - RECENT OBSERVATIONAL STUDIES OF ACE INHIBITORS AND ARBS HAVE NOT ...
A judge tossed a lawsuit brought by pharmaceutical companies to block a California law requiring advance notice of big price increases; the FDA is testing all angiotensin II receptor blockers (ARBs) ...
Patients who start their blood pressure treatment with ARB drugs continue with the same medicine to a greater extent than patients who start out with other drugs. Choosing the right drug from the ...
Over the long term, patients who survive an aortic dissection appear to do just as well treated with either beta-blockers or ACE inhibitors/ARBs rather than other antihypertensive drugs, a ...
Among four classes of blood pressure medication, angiotensin receptor blockers (ARBs) had the highest medication persistence, meaning patients taking the drugs were most likely to stay on them. This ...
Therapy-relevant gene signatures in the high risk localized renal cell carcinoma setting: Transcriptomic data from patients receiving placebo on a randomized phase III trial (PROTECT). This is an ASCO ...
Patients who start their blood pressure treatment with ARB drugs continue with the same medicine to a greater extent than patients who start out with other drugs. Choosing the right drug from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results